(1S,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-2,10-dihydroxy-7-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one

• ChemBase编号: 130455
• 分子式: C42H78N2O14
• 平均质量: 835.07372
• 单一同位素质量: 834.54530519
• SMILES: O=C1O[C@@H]([C@](O)(C)[C@H]2O[C@@H](N[C@H]([C@@H]2C)[C@H](C)C[C@](O)(C)[C@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@H]([C@@H](O[C@@H]2O[C@@H](C)[C@H](O)[C@@](OC)(C)C2)[C@H]1C)C)COCCOC)CC
• Canonical SMILES: COCCOC[C@@H]1N[C@H]2[C@H](C)C[C@@](C)(O)[C@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)[C@H]([C@H](C(=O)O[C@@H]([C@@]([C@@H](O1)[C@H]2C)(C)O)CC)C)O[C@@H]1O[C@@H](C)[C@@H]([C@](C1)(C)OC)O
• InChI: InChI=1S/C42H78N2O14/c1-15-29-42(10,49)37-24(4)32(43-30(56-37)21-52-17-16-50-13)22(2)19-40(8,48)36(58-39-33(45)28(44(11)12)18-23(3)53-39)25(5)34(26(6)38(47)55-29)57-31-20-41(9,51-14)35(46)27(7)54-31/h22-37,39,43,45-46,48-49H,15-21H2,1-14H3/t22-,23-,24+,25+,26-,27+,28+,29-,30-,31+,32+,33-,34+,35+,36-,37+,39+,40-,41-,42-/m1/s1
• InChIKey: WLOHNSSYAXHWNR-NXPDYKKBSA-N

名称和登记号

名称

• IUPAC标准名: (1S,2R,3R,6R,7S,8S,9R,10R,12R,13S,15R,17S)-9-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy}-3-ethyl-2,10-dihydroxy-7-{[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy}-15-[(2-methoxyethoxy)methyl]-2,6,8,10,12,17-hexamethyl-4,16-dioxa-14-azabicyclo[11.3.1]heptadecan-5-one
• IUPAC传统名: dirithromycin
• 商标名: Dynabac
• 别名: Dirithromycin

登记号

• CAS号: 62013-04-1
• PubChem SID: 162224734
• PubChem CID: 6917067
• ATC码: J01FA13
• CHEMBL: 1200505
• Chemspider ID: 5292341
• DrugBank ID: DB00954
• KEGG ID: D03865
• 美国药典/FDA物质标识码: 1801D76STL
• 维基百科标题: Dirithromycin
• Medline Plus: a604026

理论计算性质

• Acid pKa: 12.485339
• 质子受体: 15
• 质子供体: 5
• LogD (pH = 5.5): -2.8307562
• LogD (pH = 7.4): 0.45715556
• Log P: 2.9477377
• 摩尔折射率: 212.9535 cm^3
• 极化性: 87.141304 Å^3
• 极化表面积: 196.33 Å^2
• 可自由旋转的化学键: 12
• 里宾斯基五规则: false

分子性质

药理学性质

• 生物利用度: 10%
• 妊娠期药物分类: B
• 美国（FDA）药品许可证: Clarithromycin